LFVN vs. BSX
LFVN (LifeVantage Corporation) and BSX (Boston Scientific Corporation) are both stocks. LFVN operates in Packaged Foods (Consumer Defensive), while BSX operates in Medical Devices (Healthcare). Over the past 10 years, LFVN returned -2.84%/yr vs 7.66%/yr for BSX. At a 0.09 correlation, their price movements are largely independent.
Performance
LFVN vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LFVN achieves a 42.21% return, which is significantly higher than BSX's -49.99% return. Over the past 10 years, LFVN has underperformed BSX with an annualized return of -2.84%, while BSX has yielded a comparatively higher 7.66% annualized return.
LFVN
- 1D
- -8.59%
- 1M
- 59.76%
- YTD
- 42.21%
- 6M
- 35.18%
- 1Y
- -28.91%
- 3Y*
- 26.80%
- 5Y*
- 3.72%
- 10Y*
- -2.84%
BSX
- 1D
- -0.63%
- 1M
- -15.61%
- YTD
- -49.99%
- 6M
- -51.85%
- 1Y
- -54.23%
- 3Y*
- -2.74%
- 5Y*
- 2.89%
- 10Y*
- 7.66%
LFVN vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LFVN LifeVantage Corporation | 42.21% | -64.29% | 197.21% | 74.03% | -39.78% | -32.19% | -40.29% | 18.35% | 177.10% | -41.60% |
BSX Boston Scientific Corporation | -49.99% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 27.96% | 42.56% | 14.61% |
Correlation
The correlation between LFVN and BSX is -0.10, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.10 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Oct 6, 2004 | 0.09 |
The correlation between LFVN and BSX shifts across timeframes, from -0.10 (1 year) to 0.17 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
LFVN:
$109.13M
BSX:
$71.28B
LFVN:
$0.45
BSX:
$2.38
LFVN:
19.29
BSX:
20.06
LFVN:
0.47
BSX:
0.45
LFVN:
0.57
BSX:
3.46
LFVN:
3.27
BSX:
2.76
LFVN:
$195.32M
BSX:
$20.62B
LFVN:
$152.62M
BSX:
$14.52B
LFVN:
$8.69M
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LFVN vs. BSX — Risk / Return Rank
LFVN
BSX
LFVN vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for LifeVantage Corporation (LFVN) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LFVN | BSX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.42 | -1.57 | +1.15 |
Sortino ratioReturn per unit of downside risk | -0.23 | -2.40 | +2.17 |
Omega ratioGain probability vs. loss probability | 0.97 | 0.65 | +0.32 |
Calmar ratioReturn relative to maximum drawdown | -0.45 | -0.98 | +0.53 |
Martin ratioReturn relative to average drawdown | -0.67 | -2.25 | +1.58 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LFVN | BSX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.42 | -1.57 | +1.15 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.06 | 0.11 | -0.06 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.05 | 0.28 | -0.33 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.04 | 0.19 | -0.24 |
Drawdowns
LFVN vs. BSX - Drawdown Comparison
The maximum LFVN drawdown since its inception was -99.57%, which is greater than BSX's maximum drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for LFVN and BSX.
Loading charts...
Drawdown Indicators
| LFVN | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.57% | -89.15% | -10.42% |
Max Drawdown (1Y)Largest decline over 1 year | -71.73% | -55.91% | -15.82% |
Max Drawdown (3Y)Largest decline over 3 years | -83.90% | -55.91% | -27.99% |
Max Drawdown (5Y)Largest decline over 5 years | -83.90% | -55.91% | -27.99% |
Max Drawdown (10Y)Largest decline over 10 years | -83.90% | -55.91% | -27.99% |
Current DrawdownCurrent decline from peak | -91.16% | -55.91% | -35.25% |
Average DrawdownAverage peak-to-trough decline | -89.58% | -38.75% | -50.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 48.30% | 24.31% | +23.99% |
Volatility
LFVN vs. BSX - Volatility Comparison
LifeVantage Corporation (LFVN) has a higher volatility of 40.94% compared to Boston Scientific Corporation (BSX) at 16.24%. This indicates that LFVN's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LFVN | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 40.94% | 16.24% | +24.70% |
Volatility (6M)Calculated over the trailing 6-month period | 57.41% | 32.81% | +24.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 69.34% | 34.64% | +34.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 64.54% | 25.66% | +38.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 61.20% | 27.29% | +33.91% |
Dividends
LFVN vs. BSX - Dividend Comparison
LFVN's dividend yield for the trailing twelve months is around 2.15%, while BSX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LFVN LifeVantage Corporation | 2.15% | 2.84% | 0.88% | 8.33% | 2.42% |
Financials
LFVN vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between LifeVantage Corporation and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LFVN vs. BSX - Profitability Comparison
LFVN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, LifeVantage Corporation reported a gross profit of 34.54M and revenue of 43.72M. Therefore, the gross margin over that period was 79.0%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
LFVN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, LifeVantage Corporation reported an operating income of 1.68M and revenue of 43.72M, resulting in an operating margin of 3.8%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
LFVN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, LifeVantage Corporation reported a net income of 1.36M and revenue of 43.72M, resulting in a net margin of 3.1%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
LFVN and BSX have a correlation of -0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LFVN has higher volatility (40.94%) compared to BSX (16.24%). In terms of maximum drawdown, LFVN dropped -99.57% vs BSX's -89.15%.
LFVN currently has the higher Sharpe Ratio (-0.42 vs -1.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LFVN and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer